Medication info

Proiban (Ibandronic Acid Sodium Hydrate)

Prescription medicationSolutionIntravenous injection
Ingredient · strength
Ibandronate Sodium Monohydrate›3.375mg / 1 prefilled syringe
Manufacturer / importer
Hanil Pharmaceutical Co., Ltd.
Appearance
It is a pre-filled syringe filled with a colorless and transparent solution, accompanied by a single-use injection needle.
Packaging
1 pre-filled syringe (3ml)
Approval status
Active

MFDS item code 201306543 · Approved 2013.03.29 · Insurance code 657202481

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who receives it
Adults · Children
Adult administration
Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D as supplements. If a dose is missed on the scheduled dosing date, administer the injection as soon as possible and continue regular dosing at 3-month intervals thereafter. Patients with hepatic impairment No dose adjustment is required. Patients with renal impairment No dose adjustment is required in patients with mild or moderate renal impairment whose serum creatinine is 200 µmol/L(2.3mg/dL) or lower or whose creatinine clearance is at least 30ml/min. Administration of this drug is not recommended in patients whose serum creatinine exceeds 200 µmol/L(2.3mg/dL) or whose creatinine clearance is less than 30ml/min, as clinical experience is insufficient. Elderly patients No dose adjustment is required.
Child administration
Efficacy and safety in children 18 years of age or younger have not been studied.

Ingredients

Manufacturer
Hanil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

It is used to treat osteoporosis occurring in postmenopausal women. This medication helps increase bone density and reduce the risk of fractures. Regular use can improve bone health and maintain a healthier lifestyle.

How it is given

Adult administration

Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D as supplements. If a dose is missed on the scheduled dosing date, administer the injection as soon as possible and continue regular dosing at 3-month intervals thereafter. Patients with hepatic impairment No dose adjustment is required. Patients with renal impairment No dose adjustment is required in patients with mild or moderate renal impairment whose serum creatinine is 200 µmol/L(2.3mg/dL) or lower or whose creatinine clearance is at least 30ml/min. Administration of this drug is not recommended in patients whose serum creatinine exceeds 200 µmol/L(2.3mg/dL) or whose creatinine clearance is less than 30ml/min, as clinical experience is insufficient. Elderly patients No dose adjustment is required.

Child administration

Efficacy and safety in children 18 years of age or younger have not been studied.

Precautions

This medication must be administered intravenously, and care must be taken to avoid administration into the arteries or around the veins, as tissue damage may occur. It must not be given to patients with hypersensitivity to this medication or untreated hypocalcemia. During the use of this medication, symptoms such as gastroenteritis, diarrhea, abdominal pain, dyspepsia, nausea, and constipation may occur. If symptoms persist, it is important to consult a doctor. Musculoskeletal and skin adverse reactions such as muscle pain, joint pain, headache, and rash may also occur. Initial administration may present flu-like symptoms such as fever, chills, fatigue, and muscle pain, but they are generally mild and self-resolving. Long-term use of this medication may rarely lead to osteonecrosis of the jaw or surrounding bones in the ear, so oral conditions must be checked before dental treatment. If sudden thigh pain occurs during osteoporosis treatment, the possibility of atypical femoral fractures should be suspected, and immediate evaluation should be done. This medication can temporarily lower serum calcium levels, so it is important to treat hypocalcemia before administration and ensure adequate intake of calcium and vitamin D. It may impact kidney function, so patients with kidney disease or taking medications affecting the kidneys require regular examination and check-ups. Women who are pregnant or breastfeeding should refrain from using this medication, as safety during pregnancy has not been confirmed. This medication can cause toxicity to kidneys and liver in the event of overdose, so appropriate treatment should be sought immediately if an overdose occurs. This medication should not be mixed with other calcium-containing solutions or medications and must be administered with intravenous saline or glucose solution. After use, the syringe and needle should not be reused and must be disposed of safely.

Side effects

Gastritis, diarrhea, abdominal pain, dyspepsia, nausea, constipation, musculoskeletal pain, joint pain, muscle pain, influenza-like illness, fatigue, headache, rash, bone pain, weakness, injection site reaction, phlebitis, thrombophlebitis, hypersensitivity reaction, angioedema, facial swelling, edema, urticaria, osteonecrosis of the jaw and external auditory canal, uveitis, episcleritis, scleritis, anaphylactic reaction, shock, worsening of asthma, Stevens-Johnson syndrome, erythema multiforme, bullous dermatitis, atypical femoral and intertrochanteric fractures, atypical fractures of the iliac bone, acute renal failure, sensory impairment, dizziness, optic neuropathy, lower motor neuron lesion, tremor, unspecified gastrointestinal disorders, benign gastrointestinal neoplasms, toothache, hyperventilation, cough, shortness of breath, laryngitis, vaginitis, menopausal symptoms, multiple organ failure, death, insomnia, anxiety, tinnitus, hearing loss, hypothyroidism, lipoma, retinal hemorrhage, heart failure, urination disorders, hematuria, skin exfoliation, fracture

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from exposure to air and kept at a temperature between 1 and 30 degrees Celsius (room temperature). Proper storage will maintain the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

It is a pre-filled syringe filled with a colorless and transparent solution, accompanied by a single-use injection needle.

Package unit

1 pre-filled syringe (3ml)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.